Active Pharmaceutical Ingredient

Ibrutinib API Manufacturer & Supplier in India

Also known as: Imbruvica

CAS: 936563-96-1 BTK Inhibitor / Antineoplastic IP / BP / EP / USP Bulk Supply Available
Ibrutinib API Manufacturer India | Mediocon Inc
Ibrutinib — Pharmaceutical Grade API

Product Overview

CAS No: 936563-96-1  |  MF: C₂₅H₂₄N₆O₂  |  MW: 440.50 g/mol

Ibrutinib is a first-in-class Bruton's tyrosine kinase (BTK) inhibitor used in the treatment of B-cell malignancies including mantle cell lymphoma, CLL, and Waldenström's macroglobulinemia. Mediocon Inc supplies high-purity Ibrutinib API meeting IP/BP/EP/USP standards.

Key Features

  • First-in-class BTK inhibitor
  • IP/BP/EP/USP compliant quality
  • High chemical purity >99%
  • Suitable for oncology formulations

Applications

  • Chronic lymphocytic leukemia (CLL)
  • Mantle cell lymphoma
  • Waldenström's macroglobulinemia
  • Small lymphocytic lymphoma

Why Choose Mediocon

  • ISO 9001:2015 & GMP certified manufacturing
  • Consistent batch-to-batch quality with full CoA
  • Export-ready documentation: COO, MSDS, DMF
  • Flexible MOQ for both R&D and commercial scale
  • Dedicated QA support for regulatory filings

Product Specifications

Product NameIbrutinib
Also Known AsImbruvica
CAS Number936563-96-1
Molecular FormulaC₂₅H₂₄N₆O₂
Molecular Weight440.50 g/mol
CategoryBTK Inhibitor / Antineoplastic
AppearanceWhite to Off-white Crystalline Powder
GradeIP / BP / EP / USP

Analytical Specifications

ParameterSpecification
Assay98.0% – 102.0%
Loss on DryingNMT 0.5%
Heavy MetalsNMT 20 ppm
pHN/A
Microbial LimitsComplies with pharmacopoeia
IdentificationIR, HPLC Compliant
Packing25 kg HDPE drums / as per requirement

Sourcing, Regulatory & Export Information

Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Ibrutinib (CAS 936563-96-1) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.

Our Ibrutinib is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.

Export Markets

  • USA — FDA-registered facility; DMF support available for ANDA/NDA filings
  • Europe — EMA-compliant documentation; CEP/EDMF support on request
  • Africa & Middle East — WHO-GMP certified; competitive pricing for emerging markets
  • Southeast Asia — established logistics network; temperature-controlled shipments
  • India domestic — schedule H/X compliance; all state licensing documentation provided

Quality & Compliance

  • ISO 9001:2015 certified quality management system
  • GMP-certified manufacturing facility, Aurangabad, Maharashtra
  • Full batch traceability from raw material to finished API
  • Stability data available (ICH Q1A guidelines) for regulatory submissions
  • Dedicated QA team for customer audits and regulatory queries

Frequently Asked Questions — Ibrutinib API

What is the minimum order quantity for Ibrutinib API?
Mediocon Inc supplies Ibrutinib with a minimum order quantity of 1 kg (sample packs available for R&D). We accommodate both small R&D quantities and large commercial-scale orders. Contact our sales team at akshay@mediocon.com or +91 9309999757 for a tailored quote.
What pharmacopoeial grades of Ibrutinib does Mediocon supply?
We supply Ibrutinib conforming to IP / BP / EP / USP pharmacopoeial standards. Each batch is tested against full pharmacopoeial specifications and released with a Certificate of Analysis. Custom specifications can be accommodated for regulated markets.
What documentation is provided with Ibrutinib API?
Every shipment of Ibrutinib comes with: Certificate of Analysis (CoA), MSDS/SDS, Certificate of Origin (COO), and Drug Master File (DMF) support on request. We also provide GMP certification, ISO 9001:2015 compliance documentation, and full regulatory support for filings in USA (FDA), Europe (EMA), and other markets.
What is the lead time and shipping for Ibrutinib bulk orders?
Standard lead time for Ibrutinib is 2–4 weeks for standard orders; expedited shipments possible for urgent requirements. We ship to 40+ countries worldwide using approved pharmaceutical-grade packaging (25 kg HDPE drums / aluminium foil bags). All shipments include temperature-controlled logistics options where required by the product's storage conditions.
💬
Mediocon AI
Hello 👋 How can I help you today?